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Abstract
The vacuolar H
+-ATPase dependent transport of protons across cytoplasmic membranes in FORE (forkhead related) cells of
endolymphatic epithelium in the inner ear, intercalated cells of collecting ducts in the kidney and in narrow and clear cells
of epididymis require expression of several subunits that assemble into a functional multimeric proton pump. We
demonstrate that expression of four such subunits A1, B1, E2 and a4 all co-localize with the forkhead transcription factor
Foxi1 in a subset of epithelial cells at these three locations. In cells, of such epithelia, that lack Foxi1 we fail to identify any
expression of A1, B1, E2 and a4 demonstrating an important role for the transcription factor Foxi1 in regulating subunit
availability. Promoter reporter experiments, electrophoretic mobility shift assays (EMSA) and site directed mutagenesis
demonstrate that a Foxi1 expression vector can trans-activate an a4-promoter reporter construct in a dose dependent
manner. Furthermore, we demonstrate using chromatin immunoprecipitation (ChIP) assays that Foxi1-dependent activation
to a large extent depends on cis-elements at position 2561/2547 in the a4 promoter. Thus, we provide evidence that Foxi1
is necessary for expression of at least four subunits in three different epithelia and most likely is a major determinant for
proper assembly of a functional vacuolar H
+-ATPase complex at these locations.
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+-ATPases (v-ATPases) consist of two major
subunits: a membrane anchoring V0 domain and a catalytic V1
domain. These multimeric enzymes are mediators of both intra-
and extracellular vectorial proton transport in all eukaryotic cells.
This type of proton pump is also enriched for in the plasma
membrane of cells specialized in proton secretion such as FORE
cells of the endolymphatic sac and duct [1,2], intercalated cells of
the collecting duct in the kidney [3] and narrow and clear cells of
epididymis [4]. While there is a generic structure of v-ATPase
proton pumps derived from assemblage of ubiquitously expressed
subunits e.g. A1 and E2 many cell types present a particular
holoenzyme composition based on tissue or cell specific expression
of subunit isoforms e.g. B1 and a4 that are expressed in epithelia of
inner ear, kidney and epidiymis [5]. The V0 domain is involved in
proton translocation and consists of subunits designated by lower
case letters such as a4. A large cytosolic complex is formed by the
V1 domain and here subunits are labeled by capital letters A–H.
Subunits A1 and B1 interact with ATP while E2 is part of a stalk-
like structure that connects the V0 and V1 domains [6]. Mutations
in genes encoding several of these ‘‘tissue specific’’ subunits have
been shown to cause human disease such as recessive distal renal
tubular acidosis with (Atp6v1b1, encodes subunit B1; [7]) or in most
cases without deafness (Atp6v0a4, encodes subunit a4; [8]). In spite
of a growing body of information regarding structure – function
relationships of v-ATPase [9], intracellular targeting and recycling
[10] as well as how the coupling ratio between ATP hydrolysis and
proton transport is modulated [11] little is known regarding
upstream regulators of subunit gene expression.
This is particularly interesting since some of the subunits are
ubiquitously expressed whereas others display a more restricted
expression profile. Are ubiquitously expressed subunits regulated
by a set of common transcription factors in a generic way similar
in all tissues of expression or is the regulation of these subunits to
some extent depending on distinct sets of transcriptional regulators
varying between different tissues/celltypes? In an effort to address
this question we studied the role of a tissue specific transcription
factor, Foxi1, in regulation of both specifically e.g. B1 and a4 as
well as ubiquitously expressed subunits e.g. A1 and E2.
We can demonstrate an important role of Foxi1 as regulator of
B1 subunit expression in FORE cells of the endolymphatic
epithelium. Furthermore, we demonstrate that Foxi1 is necessary
for expression of the v-ATPase subunits A1, E2 and a4 in
endolymphatic duct, kidney collecting duct and epididymal
epithelia. Several potential Foxi1-binding cis-elements have been
PLoS ONE | www.plosone.org 1 February 2009 | Volume 4 | Issue 2 | e4471Figure 1. Confocal analysis of Foxi1 and H
+-ATPase subunits A1, B1, E2 and a4 expression in wt and Foxi12/2 endolymphatic sac
(ES) epithelium. Confocal images of inner ear sections from wt and Foxi12/2 mouse embryos (E16.5). Fluorescence images of wt ES tissue sections
stained with a specific antibody against Foxi1 (green) and the H
+-ATPase subunit A1 (red; A–B), subunit B1 (red; D–E), subunit E2 (red; G–H) and
subunit a4 (red; J–K). The nuclei (blue) were visualized using To-Pro 3. Merged images reveal that cells with a strong staining of each of the H
+-ATPase
subunits also are positive for nuclear Foxi1 staining. In sections from Foxi12/2 ES no staining could be identified for A1 (C), B1 (F), E2 (I) or a4 (L).
Scale bars 20 mm (A, D, G, J, C, F, I and L) and 10 mm (B, E, H and K) (L: lumen).
doi:10.1371/journal.pone.0004471.g001
V-ATPase Proton Pump
PLoS ONE | www.plosone.org 2 February 2009 | Volume 4 | Issue 2 | e4471V-ATPase Proton Pump
PLoS ONE | www.plosone.org 3 February 2009 | Volume 4 | Issue 2 | e4471identified in the human a4 promoter. A cluster of three such sites is
shown to interact with Foxi1, which through this interaction trans-
activates an a4 promoter reporter construct. Mutations that inhibit
interactions also significantly reduce Foxi1 dependent reporter
gene activation. Moreover, mRNA in situ experiments demon-
strate loss of mRNA encoding the ubiquitously expressed subunits
A1 and E2 in kidney epithelia that lacks Foxi1. The data presented
here establishes Foxi1 as a potential genetic regulator of subunit
availability for at least four v-ATPase subunits all expressed in
endolymphatic duct, kidney collecting duct and epididymal
epithelia.
Results
Foxi1 is required for and co-localizes with expression of
A1, B1, E2 and a4 subunits in endolymphatic sac and
duct epithelia
As can be depicted from figure 1 both the ‘‘tissue specific’’
subunits B1 and a4, expressed in the inner ear, kidney and
epididymis, as well as the ubiquitously expressed isoforms A1 and
E2 co-localizes with Foxi1 specific immunostaining. While the
different subunits as expected are expressed at the apical aspect of
epithelial FORE cells Foxi1 staining is localized to the nuclei (Fig. 1
B, E, H, K). Epithelia that lack Foxi1 expression are completely
void of B1, a4 as well as A1 and E2 expression (Fig. 1 C, F, I, L).
This strongly suggests that Foxi1 is a prerequisite for expression of
these subunits. It also agrees well with previous findings indicating
that Foxi1 mRNA is expressed in a subset of epithelial cells in the
endolymphatic duct and sac called FORE cells [1].
Foxi1 co-localizes with A1, E2 and a4 subunits in
intercalated cells of the kidney and is required for
expression
The subunits A1, E2 and a4 are expressed in a subset of
epithelial kidney cells (Fig. 2). Based on previous findings in which
Foxi1 has been established as a marker for intercalated cells [12]
we can based on co-localization with Foxi1 determine that A1, E2
and a4 all are expressed in intercalated cells. In sections from both
medulla and cortex we demonstrate a complete co-localization
between Foxi1 and the subunits A1, E2 and a4. These subunits
display a luminal staining pattern while the Foxi1 signals reside in
the nuclei (Fig. 2 A–D, G–J, M–P). Kidneys from mice lacking
Foxi1 have no detectable A1, E2 or a4 (Fig. 2 E, F, K, L, Q, R).
The overlap in expression between these subunits and Foxi1
appears to be complete i.e. all Foxi1 cells studied are positive for
A1, E2 and a4. It is known from previous work that the B1 subunit
is expressed in intercalated cells and that its expression requires
Foxi1 [12].
Foxi1 co-localizes with and is required for expression of
A1, E2 and a4 subunits in narrow and clear cells of
epididymis
Here we demonstrate that the subunits A1, E2 and a4 are
expressed in epididymis and that there is a clear overlap in
expression between Foxi1 and these subunits (Fig. 3). Since Foxi1
is a marker for proton secreting narrow and clear cells we can
conclude that not only the B1 subunit, as has previously been
shown [13], but also A1, E2 and a4 are expressed in these cell
types. Staining patterns of A1, E2 and a4 are similar to what has
been reported for the B1 subunit [13]. Epididymes lacking Foxi1
do not express any of the investigated subunits, a result that
extends the previous findings of Foxi1 as a master regulator of
subunit expression in endolymphatic epithelium and distal tubuli/
collecting ducts of the kidney to also include the epididymal
epithelium.
Foxi1 interacts with and trans-activates an ATP6V0A4
promoter reporter construct in vitro
To investigate if Foxi1 regulates expression of the a4 subunit we
studied the a4 promoter sequence and identified a cluster of three
potential forkhead binding cis-elements (Fk1-3) adhering to the
forkhead binding consensus sequence (Fig. 4; T(g/a)TTT(g/a) (t/
c); [14]). Reporter constructs encompassing these sites show a
dose-dependent Foxi1 activation (Fig. 4). Some two hundred bases
downstream from this cluster we found another potential forkhead
binding site (Fk4; Fig. 4). When any of the three sites in the cluster
were mutated there was a significant drop in reporter gene activity,
the most prominent effect was noted for the Fk3 site (Fig. 5A, B).
While mutations at this site essentially blocked Foxi1 dependent
inducibility the Fk2 site reduced Foxi1 ability to trans-activate by
approximately half and finally Fk3 reduced this effect by about a
third (Fig. 5A, B). Mutations at Fk4 did not significantly affect
reporter activity. In EMSA experiments we could demonstrate a
distinct mobility shift using a labeled double stranded oligonucle-
otide harboring the Fk1-3 cluster (Fig. 5C). We could also observe
a much weaker interaction for Fk4 (Fig. 5C) that agrees well with
the effects these sites have on total Foxi1 mediated reporter gene
activation (Fig. 5B). To investigate the nature of these interactions
we performed a series of EMSA experiments using the same
mutations as in the transfection experiments and wt (wild type)
sequences (Fig. 5D–F). While it can be deduced from figures 5D, E
and F that the unlabeled wt probe effectively competes for the Fk1,
2 and 3 protein interactions at concentrations of approximately
10-fold molar excess, compatible with bona fide interactions, the
mutated Fk1, 2 and 3 probes are significantly less efficient as
competitors and display significant competition only at ,100-fold
molar excess in most instances, a finding that agrees well with
transfection data (Fig. 5B). Taken together, these results suggest
that Foxi1 is able to interact with the ATP6V0A4 promoter at
position 2561/2547 in a sequence specific manner and this
argues in favor for direct Foxi1-mediated regulation of ATP6V0A4
gene expression in kidney, inner ear and epididymis. We have
previously shown in transfection experiments that FOXI1 interacts
with a key cis-element in the ATP6V1B1 promoter, at 2102/296,
and that this interaction is required for a dose-dependent
activation by FOXI1 [13]. In conclusion, this is compatible with
a direct role for Foxi1 in transcriptional regulation of a4 and B1
subunits and establishes these genes as Foxi1 downstream targets.
In chromatin immunoprecipitation experiments, aimed to study in
vivo interactions at the Fk1-3 cluster, we confirm that Foxi1
interactions are strongest at Fk3, slightly weaker at Fk2 and
Figure 2. Confocal analysis of Foxi1 and the H
+-ATPase subunits A1, E2 and a4 expression in wt and Foxi12/2 distal nephrons.
Confocal images of wt and Foxi12/2 kidney sections. Double staining with Foxi1 and anti H
+-ATPase antibodies showed exclusive expression of
Foxi1 protein (green) in cells of distal nephron cells co-expressing subunits A1 (red; A–D), E2 (red; G–J) and a4 (red; M–P), in both cortex as well as
medulla. Foxi1 is localized to the nuclei, which are stained blue (TOPRO 3), while the ATPase subunits are found apically, a4 (O–P) or both apically and
in the cytosol, A1 (C–D) and E2 (I–J). No expression of ATPase subunits were detected in epithelial cells from Foxi12/2 kidneys, neither in medulla (E,
K, Q) nor cortex (F, L, R). Scale bars 20 mm (L: lumen).
doi:10.1371/journal.pone.0004471.g002
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mutated we cannot detect any Foxi1 interaction (Fig. 6). An in silico
analysis of upstream regions in the A1 and E2 genes demonstrates
the presence of several potential forkhead binding sites conforming
to the consensus sequence t(g/a)TTT(g/a)(t/c) (Overdier et al.,
1997; Fig. 7).
Foxi1 is necessary for A1 and E2 encoding mRNA
expression in intercalated cells of the kidney depend
While overlapping expression patterns of the transcription
factor Foxi1 and the a4 and B1 subunits to some degree is
suggestive of a regulative role for Foxi1 it is somewhat surprising
that the ubiquitously expressed subunits A1 and E2 also appear to
be dependent on Foxi1 expression (Fig. 1–3). Although proper
assembly has been shown to be important for both intracellular
targeting/localization and stability of subunits [15,16,17] specific
regulation of ubiquitously expressed genes/proteins constitutes
another possible mode of regulation. To address the general
question: whether this is due to an Foxi1 mediated effect on
mRNA levels or if lack of the tissue specific subunits B1 and a4
would lead to destabilization of the multimeric complex and as a
consequence hereof enhanced degradation of its constituents. We
performed mRNA in situ hybridization on kidney sections from wt
and Foxi1 2/2 mice using mRNA anti-sense probes for A1 and
E2. On the same sections, as described previously [12] we
performed IHC using an antibody directed against carbonic
anhydrase II (CAII) a marker for intercalated cells in the kidney
(Fig. 8). While CAII positive intercalated cells are present in both
wt and Foxi12/2 kidneys A1 and E2 mRNA can only be
detected in wt kidneys. Thus, even though A1 and E2 belong to a
class of more broadly expressed subunits they appear to require
Foxi1 for expression of their mRNA in these cell types.
Discussion
To acidify intracellular organelles all eukaryotic cells rely on
expression of multimeric vacuolar H
+-ATPase proton pumps. In
some specialized cell types v-ATPase proton pumps are present in
the outer cellular membrane to support vectorial proton secretion
over the apical plasma membrane. While the former function is
vital for cellular adaptation and ultimately survival the latter
supports specialized functions of the multi-cellular organism.
Examples hereof include: (i) intercalated cells of the kidney distal
tubuli and collecting ducts where proton transport is essential for
maintaining proper systemic acid/base homeostasis loss of this
function leads to distal renal tubular acidosis (dRTA; [7,8]), (ii)
FORE cells in the endolymphatic epithelium of the inner ear
secretes protons into endolymph a process important for
maintaining appropriate ionic composition which in turn is vital
for conversion of acoustic sound waves into neuronal action
potentials a process critical for hearing [1,7,8] (iii) narrow and
clear cells of epididymis secretes protons into the epididymal
lumen generating a low pH that is crucial for post-testicular
maturation of spermatozoa which in turn is necessary for male
fertility [13]. At these three locations the generic pattern of
ubiquitously expressed subunits are complemented by expression
of cell specific subunits such as a4 and B1. The importance of these
specialized functions is underscored by the fact that mutations in
the gene encoding the B1 subunit, Atp6v1b1, are associated with
childhood sensorineural hearing loss and dRTA. This is also true
for the gene encoding the a4 subunit, Atp6v0a4, although deafness
is less common and appears to have a later onset, usually in the
third to fourth decade [18].
The a4 subunit is expressed in Foxi1 positive cells of
endolymphatic epithelium, intercalated cells in the kidney and
narrow and clear cells of epididymis (Fig. 1–3). The expression
appears to be restricted to Foxi1 positive cells and located in the
apical aspect of such cells as expected for a factor involved in
proton transport over the luminal plasma membrane (Fig. 1–3). It
is also clear that in epithelia lacking Foxi1 there is no detectable
expression of the a4 subunit (Fig. 1–3). To further investigate the
role of Foxi1 in regulation of a4 subunit expression we identified
four potential Foxi1 cis-elements in the Atp6v0a4 promoter Fkh1-4
(Fig. 4). While Fk4, if anything, only marginally contributes to
reporter gene activity the Fk1-3 cluster seems to be the major site
for Foxi1 dependent regulation of a4 transcription (Fig. 5). Site
directed mutagenesis of Fk3 makes the a4 promoter virtually
insensitive to Foxi1 expression in contrast to the very limited
effects on Foxi1 inducibility noted for mutations of Fk4 (Fig. 5A).
EMSA experiments demonstrate significant DNA-protein interac-
tion with Fk1-3 and only limited interactions with Fk4 (Fig. 5C)
Figure 3. Confocal analysis of Foxi1 and H
+-ATPase subunits A1, E2 and a4 expression in wt and Foxi12/2 epididymides. Confocal
images of wt and Foxi1 2/2 epididymal sections. In confocal images of wt epididymal sections, all three ATPase subunits (red) were exclusively
found in Foxi1 (green) immunoreactive epididymal cells of caput (A, G, M), corpus (B, H, N) and cauda (C, I, O). Foxi1 (green) is localized to the nuclei
(blue, TOPRO3), while the ATPase subunits are found on the apical/luminal (L) side of the cells. Staining of Foxi12/2 tissue sections showed no
detectable A1 (D, E, F), E2 (J, K, L) nor a4 (P, Q, R) subunit expression in Foxi1 deficient epididymal tissue sections. Scale bars 20 mm (L: lumen).
doi:10.1371/journal.pone.0004471.g003
Figure 4. Foxi1 can activate an ATP6V0A4 promoter reporter
construct. Sequence analysis of the ATP6V0A4 upstream region reveals
four putative FOXI1 sites located at 2561/2547 (Fk1-3) and 2358/
2352 (Fk4) relative to start of transcription (NCBI: NC_000007.12,
NM_130841). A 2754 ATP6V0A4 promoter construct was transfected
into COS7 cells using increasing amounts of Foxi1 expression plasmid. A
significant step-wise induction is shown.
doi:10.1371/journal.pone.0004471.g004
V-ATPase Proton Pump
PLoS ONE | www.plosone.org 6 February 2009 | Volume 4 | Issue 2 | e4471Figure 5. Foxi1 interact and activate ATP6V0A4 promoter reporter construct at putative forkhead binding sites Fk1-3. (A) Core TTT-
triplets of potential forkhead sites were mutated to GGG according to schematic picture. (B) Mutations reduce Foxi1-depedent reporter activation.
While Fk3 mutations seem to abolish this activation the effects on Fk1-2 are intermediate and Fk4 seems to contribute very little to Foxi1-dependent
reporter gene activation. (C) EMSA using in vitro transcribed/translated Foxi1 demonstrates interactions with [
32P] labeled oligonucleotides harboring
the 2561/2547 (Fk1-3) and 2358/2352 (Fk4) regions. The comparatively weak interaction demonstrated for Fk4 correlates well with the modest
effects on reporter gene activation seen in Fig. 5 B. (D–F) EMSA showing the 2561/2547 interaction is competed for with either wt or mutated
oligonucleotides specific for the Fk1, 2 and 3 interactions. As can be deduced, there is a higher sensitivity in EMSA competition experiments using wt
probes as compared with mutated probes – typical of a sequence specific significant interaction.
doi:10.1371/journal.pone.0004471.g005
V-ATPase Proton Pump
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former site is predominant in terms of Foxi1-mediated regulation
of a4. Furthermore, EMSA analysis of the Fk1-3 complex shows a
pattern of significantly reduced ability of the mutated oligonucle-
otides to compete for wt interactions (Fig. 5 D–F) a finding that
supports the transfection data and argues in favor of these sites as
biologically significant Foxi1 targets. Chromatin immunoprecip-
itation experiments (Fig. 6) also delineate the Fk1-3 complex as a
site for Foxi1 interactions in vivo. In conclusion, these results
support a direct role of Foxi1 in regulation of the a4 subunit in
FORE cells of the inner ear endolymphatic epithelium, interca-
lated cells of the kidney and narrow and clear cells in epidiymis.
The presence of 14 and 25 potential forkhead binding sites in the
upstream regions of the genes encoding the A1 and E2 subunits
suggests the possibility of Foxi1 as a potential regulator of these
subunits (Fig. 7). A fact supported by the finding that kidney
epithelium that lacks Foxi1 while retaining expression of carbonic
anhydrase II, a marker for intercalated cells, have no detectable
levels of neither A1 nor E2 mRNA (Fig. 8).
We have previously shown that Foxi1 through direct DNA-
protein interactions, appears to be crucial for transcription of the
Atp6v1b1 gene [13]. Mutations in a forkhead cis-element, at
2102/296, in the B1 promoter abolish both DNA-protein
interactions and Foxi1-dependent induction of promoter reporter
gene activity. This finding is supported by the absence of B1
protein in intercalated cells of the kidney and narrow and clear
cells of epididymal epithelium in mice that lack Foxi1 [12,13]. In
this study we extend this observation to also include the
endolymphatic epithelium of the inner ear (Fig. 1 D, E). Based
on the following observations we conclude that Foxi1 is necessary
for expression of the B1 subunit in these three epithelia: (i) B1 and
Foxi1 co-localize in these epithelia ([12,13]; Fig. 1 D, E), (ii) Foxi1
interacts with and can trans-activate the B1 promoter [13], (iii) in
epithelia lacking Foxi1 there is no B1 expression ([12,13]; Fig. 1 D,
E). We also present data indicating that Foxi1 is needed for
transcription of the ubiquitously expressed subunits A1 and E2 in
the kidney (Fig. 8). The structure of the multimeric vATPase
proton pump is outlined in figure 9.
Data presented here strengthens the role of Foxi1 as an
important regulator v-ATPase function at three very specific
locations: FORE cells in the endolympahtic epithelium, interca-
lated cell in the kidney and narrow and clear cells of epididymis.
Several familial and sporadic cases of deafness and dRTA have
been linked to mutations in B1 and a4 subunits [7,8,18]. In a
recent publication the first human data on mutations in FOXI1
was presented demonstrating an allelic contribution to human
deafness in patients heterozygotic for SLC26A4 mutations [19].
Materials and Methods
Immunohistochemisty
Cryosections (10 mm) were treated for antigen-retrieval as
described in [20] and blocked in 1% BSA/0.5% Triton X-100
in 16PBS buffer. The primary antibodies (ab) were diluted in
Figure 6. Chromatin Immuoprecipitation (ChIP) analysis.
Chromatin immunoprecipitation confirm presence of Foxi1- ATP6V0A4
promoter interaction at FK1-3. Transfected 3T3-L1 cells were fixed, and
chromatin was prepared by sonication. After preclearance with Protein
G Sepharose the chromatin was immunoprecipitated with or without
an Anti-6X His tag antibody (Foxi1, No Ab). The purified precipitated
DNA was used as template for PCR reactions with specific primers
covering sequence with Foxi1 binding sites (Fk1-3) or unspecific primers
(Random). ChIP analysis reveal a strong interaction of the ATP6V0A4
promoter with wt Foxi1 (Lane 1). The interaction is weakened using
promoter with mutated FK1 (Lane2) and even more weakened with Fk2
and 3 (Lanes 3–4). Using the triple mutated promoter Fk1-3 (Lane 5) no
interaction is detected.
doi:10.1371/journal.pone.0004471.g006
Figure 7. In silico identification of forkhead sites in genes encoding subunits A1 and E2. Representation of potential forkhead binding
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Three 10-minute washes in 16PBS were followed by one hour
incubation of diluted secondary ab at room temperature. Nuclei
were visualized using ToPro3 1:1000 (Molecular Probes Inc.).
After washes in 16PBS, the slides were mounted in ProLong
antifade (Molecular Probes Inc.) and imaged with a Zeiss LSM
510 META confocal microscope. Tissues from at least three
different animals were analyzed and the results were consistent.
Antibodies were diluted as follows: goat anti-Foxi1 1:500
(AbCam); rabbit anti-B1 subunit of H
+-ATPase 1:100; rabbit
polyclonal antiserum against the a4-subunit of H
+-ATPase,
(Genosys); rabbit polyclonal anti E-subunit 1:50 and rabbit
polyclonal anti A1-subunit 1:500 (supplied by Dr. S. Breton);
donkey anti-goat Alexa488 1:100 ( Molecular Probes Inc.); donkey
anti-goat Cy3 1:100 (Jackson ImmunoResearch Laboratories) and
donkey anti-rabbit Rhodamine Red 1:100 (Jackson ImmunoR-
esearch Laboratories).
Combined cRNA in situ hybridization and immunofluorescence
was performed essentially as described previously [12]. In brief,
digoxigenin (DIG) labeled cRNA probes for A1 (corresponding to
nt 233–550, GenBank Acc No. NM_007508) or E2 (correspond-
ing to nt 338–886, GenBank Acc No NM_007510) was hybridized
to mouse kidney cryosections overnight at 60uC and alkaline
phosphatase conjugated sheep-anti DIG Fab fragments (Roche)
were used for detection of bound probe. Upon completion of in
situ hybridization procedure sections were treated for antigen
retrieval using either incubation in 1% SDS in PBS at room
temperature for 5 min or by boiling in a pressure cooker for
10 min in Tris-EDTA buffer (40 mM Tris, 0.1 mM EDTA,
pH 8). Immunofluorescence was then performed using a rabbit
anti-CAII antibody (1:2000) and the nuclear marker Topro3
(Invitrogen). Stained sections were photographed on a Zeiss LSM
510 Meta system.
Cell Culture, Transient Transfections and Luciferase
Assays
The African green monkey kidney cell line COS-7 (American
Type Culture Collection, USA) was cultured in DMEM,
containing 4.5 g/liter glucose, 10% heat-inactivated calf serum,
100 U/ml Penicillin, 100 mg/ml Streptomycin (Invitrogen) and
maintained in a humidified incubator with 5% CO2 at 37uC. Cells
were grown in 24-well plates to approximately 50–80% confluence
before transfection. Transient transfections were performed with
FUGENE 6 transfection Reagent (Roche), using 120 ng of
luciferase reporter plasmid co-transfected with 40, 80 and
100 ng expression vector, in accordance to manufacturer’s
instructions. Differences in transfection efficiencies were assayed
by co-transfecting each well with 1.0 ng pRL-SV40 Renilla
luciferase plasmid (Promega). After 48 hours of transfection cells
were washed with cold PBS buffer, harvested with passive lysis
buffer (Promega) and analyzed using a Dual-Luciferase Reporter
Assay System (Promega) according to manufacturer’s protocol.
Luciferase activity was determined as fold induction relative to
cells transfected with an expression vector void of insert,
normalized to Renilla activity. Experiments were performed in
triplicates.
Plasmid Constructs and Mutants
Expression construct: The full-length human FOXI1 cloned into
pcDNA3.1/GS expression vector (GeneStorm Clone ID) was
obtained from ResGen, Invitrogen Corporation.
Figure 8. mRNA in situ hybridization and immunohistochemistry on kidney sections from wt and Foxi12/2 mice. Combined in situ
hybridization and immunofluorescence. DIG labeled cRNA probes for A1 and E2 were hybridized to wt and Foxi12/2 kidney sections and the same
sections were then subjected to immunofluorescent staining with an anti-CAII specific antibody (green) and the nuclear marker Topro3 (red). CAII
expressing cells in wt kidney displayed positive hybridization signal for both A1 and E2 probes while in Foxi12/2 kidney sections, no hybridization
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to nt. 138109234–138110074, GenBank Acc no: NT_000007) of
genomic sequence immediately upstream of exon 4 (ATG) of the
ATP6V0A4 gene (GeneID: 50617) was PCR amplified from
human DNA using custom ordered primers from Sigma-Genosys
Online Ordering. Unique KpnI and HindIII restriction sites were
incorporated at the 59 and 39 ends of the sequence, respectively, to
simplify directed cloning into KpnI and HindIII sites in the
reporter vector pGL3-basic (Promega). Primers: 1) FW: 59
GTTGATAGGATGGTGAGTGTG 39, 2) REV: 59 CCAGT-
GAATCCGCAGGT 39.
Based on information from GenBank this promoter region
contains at least four putative FOXI1 binding sites, three in the
region 2561/2547 and one in 2358/2352 relative to transcrip-
tion start site. Introduction of the triple and double mutations
(TTT.GGG and TT.GG) into the putative FOXI1 binding sites
of the 59ATP6V0A4 promoter was generated by PCR, using the
Quick Change mutagenesis kit (Stratagene) according to the
manufacturers protocol, with the following primers (mutations are
underlined): MutFK1 - FW: 59 AGA TAT ATA TAG GGA TTT
ATT TAT TTT TGA GAT GGA GTC TGG C. MutFK1-REV:
59 GCC AGA CTC CAT CTC AAA AAT AAA TAA ATC CCT
ATA TAT ATC T. MutFK2 - FW: 59 GAT ATA TAT ATT
TAG GGA TTT ATT TTT GAG ATG GAG TCT GG.
MutFK2-REV: 59 CCA GAC TCC ATC TCA AAA ATA AAT
CCC TAA ATA TAT ATA TCT. MutFK3 - FW: 59 ATA TAT
TTA TTT AGG GAT TTT TGA GAT GGA GTC TGG CTC
T. MutFK3 -REV: 59 AGA GCC AGA CTC CAT CTC AAA
AAT CCC TAA ATA AAT ATA T. MutFK4 - FW: 59 CAG
GAT TTC ACC ATG GGG GCC AGG CTA GTC TC.
MutFK4-REV: 59 GAG ACT AGC CTG GCC CCC ATG GTG
AAA TCC TG. The sequence of all constructs was verified by
using ABI PRISM 310 Genetic Analyzer (Applied Biosystems).
Electrophoretic mobility shift assay (EMSA)
In vitro transcription and translation: In vitro transcription/translation
was performed according to the manufacturer’s protocol using
TnT Quick Coupled Transcription/translation Systems (Promega)
with [
35S] methionine and 2 mg expression plasmid.
Electrophoretic mobility shift assay: Single stranded oligonucleotides
were ordered custom made (Sigma) and annealed in annealing
buffer over night. Double stranded oligonucleotides were labeled
using Klenow polymerase and [a-
32P]dCTP and isolated from
unincorporated nucleotides by gel extraction. For each binding
reaction; 50,000 cpm of labeled probe was incubated with 2 mlo f
in vitro t/t FOXI1 protein and 500 ng of poly dI:dC in a binding-
buffer containing 5 mM HEPES, pH 7.9, 26% glycerol, 1.5 mM
MgCl2, 0.2 mM EDTA, 0.5 mM dithiothreitol, and 0.5 mM
PMSF with 100 mM KCl at room temperature for 15 min.
Competition experiments were performed in the presence of 10 to
50-fold molar excess of unlabeled wt or mutated probes,
respectively. Samples were run in 6% non-denaturing polyacryl-
Figure 9. Schematic illustration of the vacuolar H
+-ATPase proton pump. Subunits specifically expressed in endolymphatic epithelium of
the inner ear, intercalated cells of kidney and narrow and clear cells of the epididymis in bold.
doi:10.1371/journal.pone.0004471.g009
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380 mM glycine; 2 mM EDTA) at 4uC. Subsequently, gels were
dried and subjected to autoradiography.
Chromatin Immunoprecipitation (ChIP) assays
3T3-L1 cells were transfected with a Foxi1-His and ATP6V0A4
promoter constructs using FUGENE 6 transfection Reagent
(Roche). Chromatin immunoprecipitation was performed using
EZ ChIP kit (Upstate) according to manufacture’s instructions,
with addition of a 1 h pre clear with Protein G Sepharose.
Immunoprecipitation were carried out overnight at 4uC with an
Anti-6X His tag antibody (Abcam). ChIP primers were as follows :
Foxi1 Forward 59-GGATGGTGAGTGTGATATTT-39; Foxi1
Reverse 59-CATTTGAGGTCAGGAGTTTG-39; Random For-
ward 59-CCCGGTACCTTATAAGTTTCA-39; Reverse 59-
GTCCCTCCTGGAAGGACAAA-39.
Statistics
All values are given as mean6SEM. Student’s t-test was used
for statistical analysis. A p-value of less than 0.05 was considered to
be significant.
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